Evidence map›Paper›PMID 30555224›Full record

ArticlePatient preference and adherence2018

Continuum of care among HIV-1 positive patients in a single center in Italy (2007-2017).

Filippo Lagi, Seble Tekle Kiros, Irene Campolmi, Susanna Giachè, Pier Giorgio Rogasi, Marcello Mazzetti, Filippo Bartalesi, Michele Trotta, Patrizia Nizzoli, Alessandro Bartoloni and 1 more

Abstract read
In one paragraph

Article in Patient preference and adherence, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Filippo LagiInfectious Disease Unit, Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.
Seble Tekle KirosInfectious Disease Unit, Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.
Irene CampolmiInfectious Disease Unit, Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.
Susanna GiachèInfectious Disease Unit, Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.
Pier Giorgio RogasiInfectious and Tropical Disease Unit, Azienda Ospedaliero - Universitaria Careggi, Florence, Italy, sterrantinok@gmail.com.
Marcello MazzettiInfectious and Tropical Disease Unit, Azienda Ospedaliero - Universitaria Careggi, Florence, Italy, sterrantinok@gmail.com.
Filippo BartalesiInfectious and Tropical Disease Unit, Azienda Ospedaliero - Universitaria Careggi, Florence, Italy, sterrantinok@gmail.com.
Michele TrottaInfectious and Tropical Disease Unit, Azienda Ospedaliero - Universitaria Careggi, Florence, Italy, sterrantinok@gmail.com.
Patrizia NizzoliDepartment of Pharmaceuticals, USL Toscana Centro, Florence, Italy.
Alessandro BartoloniInfectious Disease Unit, Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.
Gaetana SterrantinoInfectious and Tropical Disease Unit, Azienda Ospedaliero - Universitaria Careggi, Florence, Italy, sterrantinok@gmail.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimThis study aimed to determine rates of retention in care, viral suppression, and use of antiretroviral therapy (ART) and identify risk factors for loss to follow-up (FU) in an adult cohort from a tertiary teaching hospital in Florence, Italy.

methodsWe included all newly diagnosed HIV-infected patients aged >18 years who were linked to our clinic from July 2007 to December 2015. On July 31, 2017, we evaluated the proportion of patients retained in care, on ART, and having HIV RNA <50 copies/mL. We assessed predictors of loss to FU through univariate and multivariate analyses.

resultsWe included 423 patients. By July 2017, 23 (5.5%) patients died, 25 (5.9%) moved to a different center, and 64 (15.1%) were lost to follow-up. Among the remaining 311 patients (73.5%), 96.5% were on ART and 95% had HIV RNA <50 copies/mL. After adjustment for sex, age at diagnosis, origin, and risk of transmission, our results showed a lower retention rate in those not on ART at the end of the follow-up (adjusted HR [aHR]: 10.33, 95% CI 5.80-18.40,

conclusionIn our hospital in Florence, we found a gap in retention in care among foreigners, people <35 years old, and those who were not in treatment at the end of the follow-up. The results of this study may help to identify opportunities for appropriate future interventions.

Indexed as

90-90-90 targetcontinuum of careHIV-1Italypredictors associated to loss to follow-upretention in care

Identifiers

PMID30555224
PMCPMC6280894

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.